ATHE - ALTERITY THERAPEUTICS LTD

QQQ $ 441.33 $ 0.96 (0.22 %)

DIA $ 394.43 $ 3.52 (0.9 %)

SPY $ 520.56 $ 2.98 (0.58 %)

TLT $ 90.69 $ 0.44 (0.49 %)

GLD $ 216.93 $ 3.37 (1.58 %)

Previous Close

$ 2

Open

$ 2.06

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.06 - $ 2.06

52 Week Range

$ 1.55 - $ 5.41

Volume

44,659

Average Volume

Market Cap

81.33M

Beta (5Y Monthly)

$ 1.72

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Alterity Therapeutics Phase 2 Data Monitor...
05/08/2024 11:27:34

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
05/03/2024 12:06:34

Alterity Therapeutics Announced Presentati...
04/29/2024 00:42:41

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing d...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
04/24/2024 16:31:39

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
04/23/2024 20:31:12

Alterity Therapeutics Parkinson's Disease ...
04/17/2024 11:26:43

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated...

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
04/15/2024 20:31:28

why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Ultragenyx Pharmaceutical Shares Are T...
04/15/2024 18:11:35

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
04/15/2024 16:31:47

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
04/15/2024 12:07:12

Benchmark Reiterates Speculative Buy on Al...
03/07/2024 13:43:06

Benchmark analyst Robert Wasserman reiterates Alterity Therapeutics (NASDAQ:ATHE) with a Speculative Buy and maintains $4 pr...

Alterity Therapeutics Earlier Announced A ...
02/23/2024 01:19:19

-ASX Announcement

Trading Halt: Halt status updated at 6:55:...
02/22/2024 23:55:04

Alterity Therapeutics Shares Halted; Co Re...
02/21/2024 22:43:24

Trading Halt: Halted at 5:41:10 p.m. ET - ...
02/21/2024 22:41:14

12-health-care-stocks-moving-in-tuesdays-pre-market-session

12 Health Care Stocks Moving In Tuesday's ...
02/06/2024 13:06:31

Alterity Therapeutics Phase 2 Data Monitor...
02/06/2024 12:26:27

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated...

Alterity Therapeutics Highlights Successes...
01/22/2024 12:29:37

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated...

12 Health Care Stocks Moving In Monday's A...
01/15/2024 21:30:51

Alterity Therapeutics Names Phillip Hains ...
12/21/2023 06:22:25

The appointment of Mr. Hains follows the resignation of Kathryn Andrews, who has been CFO since 2014. Ms. Andrews has chosen to...